Showing results (191-200 of 366) with videos related to
Sort By:
Pageof 37
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomasGhassan Allo, Marcus Q Bernardini, Ren-Chin Wu, et al.International Journal of Cancer|January 16, 2013
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesisGong Yang, Imelda Mercado-Uribe, Asha S Multani, et al.BMC Systems Biology|July 25, 2014
Knowledge-fused differential dependency network models for detecting significant rewiring in biological networksYe Tian, Bai Zhang, Eric P Hoffman, et al.Human Pathology|September 6, 2017
Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinomaDeyin Xing, Yohan Suryo Rahmanto, Felix Zeppernick, et al.International Journal of Data Mining and Bioinformatics|January 8, 2010
Biomarker identification by knowledge-driven multilevel ICA and motif analysisLi Chen, Jianhua Xuan, Chen Wang, et al.The American Journal of Pathology|September 18, 2007
Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motilityMartina Bazzaro, Antonio Santillan, Zhenhua Lin, et al.Carcinogenesis|October 3, 2012
Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathwayYeong-In Yang, Kyung-Tae Lee, Hee-Juhn Park, et al.Plos One|June 4, 2016
Expression of Cell Competition Markers at the Interface between p53 Signature and Normal Epithelium in the Human Fallopian TubeMasahiko Kito, Daichi Maeda, Yukitsugu Kudo-Asabe, et al.Gynecologic Oncology|December 14, 2004
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinomaBen Davidson, Mari Bukholt Elstrand, Michael T McMaster, et al.Archives of Pathology & Laboratory Medicine|November 29, 2002
Proteomic approaches to tumor marker discoveryAlex J Rai, Zhen Zhang, Jason Rosenzweig, et al.Pageof 37